Japon - anglais - すりの適正使用協議会 RAD-AR Council, Japan

organon - mirtazapine - yellow-red tablet, major axis: 13 mm, minor axis: 7 mm, thickness: 4.6 mm

Philippines - anglais - FDA (Food And Drug Administration)

ambica international corp. - pregabalin - capsule - 100mg

Philippines - anglais - FDA (Food And Drug Administration)

n/a; importer: ambica international corporation; distributor: ambica international corporation - pregabalin - capsule - 100 mg

Australie - anglais - Department of Health (Therapeutic Goods Administration)

dejay medical & scientific pty ltd - 45052 - transport wheelchair, collapsible - transport wheelchair, collapsible

Australie - anglais - Department of Health (Therapeutic Goods Administration)

dejay medical & scientific pty ltd - 45052 - transport wheelchair, collapsible - eio stroller/wheelchair that is transportable and collapsible

Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - mirtazapine - oral tablet - 30mg

États-Unis - anglais - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - mirtazapine (unii: a051q2099q) (mirtazapine - unii:a051q2099q) - mirtazapine tablets, usp are indicated for the treatment of major depressive disorder. the efficacy of mirtazapine in the treatment of major depressive disorder was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the diagnostic and statistical manual of mental disorders – 3rd edition (dsm-iii) category of major depressive disorder (see clinical pharmacology). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. the effectiveness of mirtazapine in hospitalized dep

États-Unis - anglais - NLM (National Library of Medicine)

remedyrepack inc. - mirtazapine (unii: a051q2099q) (mirtazapine - unii:a051q2099q) - mirtazapine tablets are indicated for the treatment of major depressive disorder. the efficacy of mirtazapine tablets in the treatment of major depressive disorder was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the diagnostic and statistical manual of mental disorders – 3rd edition (dsm-iii) category of major depressive disorder (see clinical pharmacology). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least 5 of the following 9 symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt, or suicidal ideation. the effectiveness of mirtazapine tablets

Irlande - anglais - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - mirtazapine - orodispersible tablet - 45 milligram(s) - other antidepressants; mirtazapine

Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - mirtazapine - orodispersible tablet - 45mg